Skip to the page

Data / Form D filings / Summit Therapeutics Inc.

Summit Therapeutics Inc.: Form D filings

Summit Therapeutics Inc., a biotechnology company in Miami, FL, filed 6 Form D notices with the SEC between 2014 and 2024. The latest, on September 26, 2024, reports $235 million sold of a $235 million offering to 17 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
601 Brickell Key Drive, SUITE 1000, Miami, FL, 33131
Phone
(305) 203-2034
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1599298

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 26, 2024New notice$234,999,889$234,999,88917Sep 11, 2024sec.gov
Jun 18, 2024New notice$199,999,998$199,999,9982Jun 3, 2024sec.gov
Nov 23, 2020New notice$50,000,000$50,000,0003Nov 6, 2020sec.gov
Jan 2, 2020New notice$47,400,000$47,400,0001Dec 24, 2019sec.gov
Jan 18, 2019New notice$25,000,000$25,000,0001Jan 9, 2019sec.gov
Mar 4, 2014New notice$11,644,000$11,644,00013Mar 4, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Manmeet SoniExecutive Officer, Director
Robert DugganExecutive Officer, Director
Jeff HuberDirector
Mahkam ZanganehExecutive Officer, Director
Mostafa RonaghiDirector
Alessandra CesanoDirector
Kenneth ClarkDirector
Yu XiaDirector
Robert BoothDirector

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Sep 23, 2024 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Summit Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.